Drug intelligence / Profile preview

Belotero Revive

Development stage: Unknown
Lead developer: Merz Aesthetics
Administration: Intradermal

Overview

Belotero Revive is an injectable dermal filler and skin booster developed by Merz Aesthetics. It is a sterile, transparent, cross-linked hyaluronic acid (20 mg/mL) hydrogel combined with glycerol (17.5 mg/mL). Utilizing Merz's proprietary Cohesive Polydensified Matrix (CPM) technology, the product is designed for smooth integration into the superficial to mid-dermal layers of the skin. Unlike traditional fillers that focus on volume restoration, Belotero Revive is indicated for skin revitalization, improving hydration, elasticity, and firmness, and reducing fine lines in early-onset photo-damaged skin. It acts as a humectant and structural support agent within the extracellular matrix.

Brand names: Belotero Revive

Targets

COL (Collagen type XXI alpha 1 chain)

Beyond the preview

Go deeper on Belotero Revive.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Belotero Revive.

Explore the full profile